iShares Genomics Immunology and Healthcare ETF
IDNA
IDNA
5 hedge funds and large institutions have $22.3M invested in iShares Genomics Immunology and Healthcare ETF in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+2
Holders Change %
+66.67%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
RIA
Realta Investment Advisors
Wilmington,
Delaware
|
$12K |
| 2 |
UBS Group
Zurich,
Switzerland
|
$9K |
Top Sellers
| 1 |
BlackRock
New York
|
$22M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
BlackRock
New York
| $22M | -$2.54M | -85,000 | -10% |
|
2
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $359K | – | – | – |
|
|
RIA
3
Realta Investment Advisors
Wilmington,
Delaware
| $12K | +$12K | +407 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $9K | +$6.96K | +232 | +341% |
|
|
OPS
5
Orion Portfolio Solutions
Omaha,
Nebraska
| $1K | +$1K | +29 | New |
|